Medication for borderline personality disorder: A survey at a secure hospital

References

• Stern A. Psychoanalytic investigation of and therapy in the borderline group of neuroses. Psychoanal Q 1938;7:467–89.
   Google Scholar
• Coid J, Yang M, Bebbington P, Moran P, Brugha T, Jenkins R, . Borderline personality disorder: Health service use and social functioning among a national household population. Psychol Med 2009;39:1721–31.
   PubMed Web of Science ®Google Scholar
• Winston AP. Recent developments in borderline personality disorder. Adv Psychiatr Treat 2000;6:211–17.
   Google Scholar
• Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HI, . Two-year randomized controlled trial and follow-up of dialectical behaviour therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006;63:757–66.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Dobo ED, Sickel AE, Trikha A, Levin A, . Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998;155:1733–9.
   PubMed Web of Science ®Google Scholar
• Lart R, Payne S, Beaumont B, MacDonald G, Mistry T. Women and secure psychiatric services: A literature review. York: NHS Centre for Reviews and Dissemination, University of York; 1999.
   Google Scholar
• National Institute for Health and Clinical Excellence. Borderline personality disorder: Treatment and management [updated 22 March 2011; cited 26 March 2011] (Available from: http://www.nice.org.uk/CG78).
   Google Scholar
• Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010; 196:4–12.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Comp Psychiatry 2001;42:144–50.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004;65:28–36.
   PubMed Web of Science ®Google Scholar
• Mental Health Act 2007 [cited 26 March 2011] (Available at: www.legislation.gov.uk/ukpa/2007/12/contents).
   Google Scholar
• British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary No. 60. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2010.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th. Text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• SPSS Inc. SPSS for Windows release 14.0.2. Chicago, IL: SPSS Inc; 2006.
   Google Scholar
• Ventura MA, Green MF, Shaner A, Liberman RP. Training and quality assurance with the brief psychiatric rating scale: “The drift buster”. Int J Methods Psychiatr Res 1993;3:221–44.
   Web of Science ®Google Scholar
• Baker-Glenn E, Steels M, Evans C. Use of psychotropic medication among psychiatric out-patients with personality disorder. Psychiatrist 2010;34:83–6.
   Google Scholar
• Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998; 59:103–7.
   PubMed Web of Science ®Google Scholar
• Chegappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477–84.
   PubMedGoogle Scholar
• Swinton M. Clozapine in severe borderline personality disorder. J Forensic Psychiatry 2001;12:580–91.
   Web of Science ®Google Scholar
• Taylor D, Paton C, Kapur S. Maudsley prescribing guidelines. London: Informa Healthcare; 2009.
   Google Scholar
• Royal College of Psychiatrists. Use of licensed medicines for unlicensed applications in psychiatric practice (College Report CR142). London: Royal College of Psychiatrists; 2007.
   Google Scholar
• Zimmerman M, McGlinchey JB, Chelminski I, Young D. Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview. Psychol Med 2008;38:199–210.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 1999;40: 245–52.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, . Axis II comrbidity of borderline personality disorder. Compr Psychiatry 1998;39:296–302.
   PubMed Web of Science ®Google Scholar